Literature DB >> 22693350

Wt1 and epicardial fate mapping.

Carsten Rudat1, Andreas Kispert.   

Abstract

RATIONALE: The embryonic epicardium is a crucial cell source of the cardiac fibrous skeleton as well as of the coronary system. Genetic lineage tracing systems based on Wt1 regulatory sequences provided evidence that epicardium-derived cells also adopt a myocardial fate in the mouse.
OBJECTIVE: To define the adequacy of Wt1-based lineage tracing systems for epicardial fate mapping. METHODS AND
RESULTS: Using in situ hybridization analysis and immunofluorescence on tissue sections, we detected endogenous expression of Wt1 mRNA and Wt1 protein in the proepicardium and epicardium and also in endothelial cells throughout cardiogenesis. Expression analysis of a sensitive GFP reporter showed that recombination mediated by cre recombinase in the Wt1(creEGFP) line occurs randomly and sporadically in all cells of the embryo. Recombination in cardiomyocytes was found in the linear heart tube before establishment of a (pro)epicardium. In contrast, the tamoxifen-inducible Wt1(creERT2) mouse line mediated poor and variable recombination in the epicardium. Recombination in cardiomyocytes was not detected in this case.
CONCLUSIONS: Frequently used Wt1 based cre-mediated lineage tracing systems are not suitable for epicardial fate mapping because of endogenous endothelial expression of Wt1, ectopic recombination (Wt1(creEGFP)), and poor recombination efficiency (Wt1(creERT2)) in the developing heart. We conclude that claims of a cardiomyocyte fate of epicardial cells in the mouse are not substantiated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22693350     DOI: 10.1161/CIRCRESAHA.112.273946

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  69 in total

1.  Pharmacological inhibition of TGFβ receptor improves Nkx2.5 cardiomyoblast-mediated regeneration.

Authors:  Wen-Pin Chen; Yuan-Hung Liu; Yi-Jin Ho; Sean M Wu
Journal:  Cardiovasc Res       Date:  2014-10-31       Impact factor: 10.787

2.  Fibrocytes Regulate Wilms Tumor 1-Positive Cell Accumulation in Severe Fibrotic Lung Disease.

Authors:  Vishwaraj Sontake; Shiva K Shanmukhappa; Betsy A DiPasquale; Geereddy B Reddy; Mario Medvedovic; William D Hardie; Eric S White; Satish K Madala
Journal:  J Immunol       Date:  2015-09-14       Impact factor: 5.422

Review 3.  Redirecting cardiac growth mechanisms for therapeutic regeneration.

Authors:  Ravi Karra; Kenneth D Poss
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

Review 4.  The epicardium as a hub for heart regeneration.

Authors:  Jingli Cao; Kenneth D Poss
Journal:  Nat Rev Cardiol       Date:  2018-10       Impact factor: 32.419

5.  Epicardial-derived adrenomedullin drives cardiac hyperplasia during embryogenesis.

Authors:  Sarah E Wetzel-Strong; Manyu Li; Klara R Klein; Toshio Nishikimi; Kathleen M Caron
Journal:  Dev Dyn       Date:  2014-02       Impact factor: 3.780

6.  In Vitro Culture of Epicardial Cells From Mouse Embryonic Heart.

Authors:  Sindhu Ramesh; Anamika Singh; Dasan M Cibi; Derek J Hausenloy; Manvendra K Singh
Journal:  J Vis Exp       Date:  2016-04-27       Impact factor: 1.355

Review 7.  Cardiac stem cell niches.

Authors:  Annarosa Leri; Marcello Rota; Toru Hosoda; Polina Goichberg; Piero Anversa
Journal:  Stem Cell Res       Date:  2014-09-08       Impact factor: 2.020

Review 8.  New therapeutics based on emerging concepts in pulmonary fibrosis.

Authors:  Vishwaraj Sontake; Prathibha R Gajjala; Rajesh K Kasam; Satish K Madala
Journal:  Expert Opin Ther Targets       Date:  2018-11-28       Impact factor: 6.902

Review 9.  Developmental origin and lineage plasticity of endogenous cardiac stem cells.

Authors:  Maria Paola Santini; Elvira Forte; Richard P Harvey; Jason C Kovacic
Journal:  Development       Date:  2016-04-15       Impact factor: 6.868

Review 10.  Genetic tools for identifying and manipulating fibroblasts in the mouse.

Authors:  Jessica M Swonger; Jocelyn S Liu; Malina J Ivey; Michelle D Tallquist
Journal:  Differentiation       Date:  2016-06-21       Impact factor: 3.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.